Pharma | Pharmaceutical industry | News | Healthcare

GSK maintains the top place in the Access to Medicines rating in 2022; J&J and AZ followed the list The 2022 Access to Medicine Index was...

Multiple Myeloma | News | Blogs | FDA and EMA approvals | Updates on clinical guidelines

November 07, 2022 Blenrep failed to demonstrate superior PFS versus PomDex in RRMM patients GSK announced that Blenrep (belantamab...

2022 FDA Drug Approvals

November 17, 2022 Tzield approved for delaying Stage 3 T1D in adults and pediatrics with Stage 2 T1D Provention Bio announced that Tzield...

Merck and Moderna agreed to develop and commercialize a cancer vaccine | iPharmaCenter

Merck and Moderna have announced that Merck has exercised its option to collaborate and commercialize the cancer vaccine. The companies...

NICE ASSESSMENT OUTCOMES

October 19, 2022 BeiGene's Brukinsa was recommended for Waldenstrom's macroglobulinemia. BeiGene's Brukinsa (zanubrutinib) was...

China Drug Approvals | NMPA Drug Approvals | Pharma | Healthcare | China

November 11, 2022 AstraZeneca announced the availability of Soliris in China for PNH and aHUS. AstraZeneca announced that Soliris...

Pharmaceutical Companies Deals and acquisitions | Sanofi | Novo Nordisk

05 October 2022 Pfizer completed the acquisition of Global Blood Therapeutics. Pfizer announced that it had completed the acquisition of...

Sanofi gave a statement on the U.S. Zantac litigation | iPharmaCenter

Sanofi issued a position statement on the U.S. Zantac litigation. On September 12, 2019, FDA stated that ranitidine-containing medicines,...

AbbVie's JAK inhibitor, Rinvoq, was approved for UC and nr-axSpA in Europe | iPharmaCenter

AbbVie announced that its Janus Kinase (JAK) inhibitor was approved by the European Commission for non-radiographic axial...

Top 20 healthcare companies | iPharmaCenter | Top healthcare companies by revenues

Fortune has published the list of top 500 companies, and here is the list of top 20 health care companies. CVS Health CVS Health is an...

Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter

Merck has announced the results of two Phase 3 trials of Keytruda - in combination with Lenvima in unresectable hepatocellular carcinoma...

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS

June 30, 2022 HAS agreed to continue reimbursement of Kymriah for DLBCL Kymriah (tisagenlecleucel) was reassessed for the patients with...

TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022

REVENUES OF TOP BIOPHARMACEUTICAL COMPANIES 2022 1 CHF = 1.01 USD, 1 GBP = 1.16USD; 1EUR= 0.99 USD; 1DKK = 0.13 USD Merck revenues...

Expected best selling pharmaceuticals/drugs of 2022

EXPECTED BEST SELLING PRODUCTS OF 2022 Comirnaty (Pfizer) Comirnaty is a messenger RNA (mRNA) based COVID vaccine developed by Pfizer and...

Health Canada Drug Approvals | Healthcare and Pharmaceutical News of Canada | News | Blogs | Canada

Health Canada approved Rybrevant for EGFR exon insertion mutation NSCLC. Janssen announced that Health Canada issued a Notice of...

Top pharmaceutical companies by revenues in 2021

TOP BIOPHARMACEUTICAL COMPANIES BY REVENUES IN 2021 Revenues in billions Also read: Italy healthcare system 1. JOHNSON AND JOHNSON Q1...

Australia Drug Approvals | Drugs approved by TGA

September 30, 2022 TGA approved Moderna bivalent vaccine as a booster dose. The Therapeutic Good Administration granted provisional...

Collaborations for drug development in Pharma and Healthcare |

Exscientia and Sanofi collaborated to develop AI-driven pipeline medicines, UK based drug discovery companies may receive payments up to...

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

Jan 14, 2022 EMA asked to add another adverse event to the label of Vaxzevria and Janssen COVID19 vaccine EMA asked to change the label...

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

India started vaccination of adolescents; Bharat Biotech says Covaxin demonstrated robust efficacy and safety in people of age 2-18 years...

Top 20 pharmaceutical companies by revenues in 2020

PHARMACEUTICAL COMPANIES BY REVENUES IN 202O Also check: Top pharmaceutical companies by revenues in 2021 The other big biopharmaceutical...

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

Pfizer has announced that the Food and Drug Administration approved Paxlovid (nirmatrelvir tablets and ritonavir tablets) to treat...

~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio

Novartis announced that the US FDA approved Leqvio (inclisiran) to decrease the lower low-density lipoprotein cholesterol (bad...

Myasthenia Gravis News | FDA and EMA approvals |

FDA approved Vyvgart for Myasthenia Gravis FDA announced that it had approved Vyvgart (efgartigimod) for generalized myasthenia gravis...

HIV News and media blogs | Viiv's Apretude approved in the US for HIV prevention

Viiv's Apretude approved in the US for HIV prevention ViiV, an HIV-specialized company owned by GSK, Pfizer, and Shionogi, announced that...

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

December 2021 IQWIG says Rinvoq has added benefit at higher doses, but with safety issues IQWIG has assessed the benefit assessment of...

China released the 2022 NDRL list, Chinese pharma benefited from the list

China has released the 2021 Drug catalog, which included 2,860 drugs, out of which 1,486 drugs are Western drugs. Reuters reported a...

PBAC News Updates

21 November 2021 Australia included Takhzyro in PBS scheme Australia included Takhzyro (lanadelumab) in the Pharmaceutical Benefits...

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

Ronapreve (casirivimab / imdevimab) approved for treating and preventing COVID19 in adults and adolescents Celltrion's Regkirona...

American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates

ABBVIE RINVOQ AbbVie presented the Phase 3 SELECT-PsA 1 and SELECT-PsA 2 data of Rinvoq in patients with psoriatic arthritis. Rinvoq...

Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

The U.N. agency World Health Organisation (WHO) had made a statement on the next WHO chief. WHO announced that the member states proposed...

WHO granted EUL to Covaxin; acclaims easy storage requirement

WHO has announced that it has granted emergency use listing for Covaxin developed by Bharat Biotech. This adds another vaccine to the...

FDA approved Novartis Scembli for chronic myeloid leukemia

Novartis announced that the US FDA had approved Scemblix (asciminib) for treating patients with chronic myeloid leukemia. Scemblix...

Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval

The US FDA approved Biogen's Aduhelm (aducanumab) for Alzheimer's disease. It is the first approved product for AD since 2003 and acts by...

ASCO 2021

NOVARTIS Kymriah demonstrated a strong response in patients with relapsed or refractory follicular lymphoma Novartis presented the...

NHS England News | NHS to offer Tagrisso for lung cancer patients

NHS to offer Tagrisso for lung cancer patients NHS England announced that it would roll out Tagrisso (osimertinib) for lung cancer...

United Kingdom COVID19 News | Has Britain reached herd immunity?

As of May 9th, one-third of adults in England received two doses of the COVID19 vaccine NHS England announced that one-third of adults in...

CMS News | US Healthcare News | Medicare and Medicaid News |

CMS adopted new provisions to reduce the out-of-pocket cost for patients who rely on Federal Health Insurance Marketplaces The Centers...

European Commission approved Benlysta for active lupus nephritis

GlaxoSmithKline announced that it received approval for expanded use of Benlysta (belimumab) for lupus nephritis in Europe. The drug is...

France COVID-19 Updates | COVID-19 News in Europe

HAS recommended the user of mRNA vaccines for a population already administered with AstraZeneca vaccine AstraZeneca’s COVID19 vaccine...

American Academy of Dermatology (AAD VMX) Virtual Meeting

AMGEN Otezla Otezla presented a significant improvement in the disease severity in mild-to-moderate patients, according to the Phase 3...

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

GSK has announced that the US FDA has approved Jemperli (dostarlimab), a programmed death receptor-1 (PD-1) for endometrial cancer. The...

Multiple sclerosis News | Tysabri is now available as SC in Europe

Tysabri is now available as SC in Europe Biogen announced that the European Commission had approved the new subcutaneous form of Tysabri...

Gilead’s Trodelvy approved for triple-negative breast cancer in US

Gilead’s Trodelvy (sacituzumab govitecan) has announced that it has received approval from the US FDA for triple-negative breast cancer...

England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche

NHS England recommended the use of Roche's Phesgo (pertuzumab/trastuzumab) for treating HER2-positive breast cancer. HER2-positive breast...

CHMP Opinions | EMA drug approvals

March 2021 CHMP Positive Opinion Verastem’s Copiktra (duvelisib) received CHMP positive opinion for treating CLL and FL CHMP gave a...

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

Australia prefers Pfizer vaccine, US agency raises concerns over the information released by AstraZeneca, EMA’s safety committee says the...